JPMorgan Chase & Co’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152 | Sell |
|
|||||
|
2025
Q1 | $139 | Sell |
|
|||||
|
2024
Q4 | $401 | Sell |
|
|||||
|
2024
Q3 | $286 | Hold |
|
|||||
|
2024
Q2 | $329 | Buy |
|
|||||
|
2024
Q1 | $472 | Buy |
|
|||||
|
2023
Q4 | $654 | Buy |
|
|||||
|
2023
Q3 | $584 | Buy |
|
|||||
|
2023
Q2 | $731 | Hold |
|
|||||
|
2023
Q1 | $0 | Hold |
|
|||||
|
2022
Q4 | $1K | Sell |
|
|||||
|
2022
Q3 | $2K | Buy |
|
|||||
|
2022
Q2 | $3K | Sell |
|
|||||
|
2022
Q1 | $19K | Buy |
|
|||||
|
2021
Q4 | $30K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $269K | Hold |
|
|||||
|
2021
Q1 | $264K | Buy |
|